NEW YORK (GenomeWeb) – The Crohn's & Colitis Foundation of America (CCFA) today announced a partnership with the American Gastroenterological Association (AGA) and Janssen Biotech to create a grant program promoting research into the epigenetic factors of inflammatory bowel disease.

Under the program, the partners will together provide $100,000 per year for three years to support research on the role of epigenetics in the development or treatment of IBD.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.